drugset / Trial / NCT05468190
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
Non-randomizedParallel-groupOpen-labelTreatment
Summary
As a phase I clinical research，this study plans to evaluate the safety and tolerability of CD70-targeting CAR-T cells in the treatment of CD70-positive advanced/metastatic solid tumors, and obtain recommended doses and infusion patterns.
Timeline
- Start
- 2022-07-17
- Primary completion
- 2024-07-17
- Completion
- 2025-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD70 CAR-T cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | CD70 CAR-T cells | Cell therapy | 1e+07 cells/kg | Intravenous |